Article Text
Letters to the editor
Intravenous montelukast in acute asthma: expensive aminophylline?
Statistics from Altmetric.com
We read with interest the recent paper by Dockhornet al comparing the effects of single doses of intravenous and oral montelukast on forced expiratory volume in one second (FEV1) in patients with chronic persistent asthma.1 We agree with the accompanying editorial, that a study of montelukast in acute severe asthma is now warranted.2 Indeed, few published studies have examined the use of leukotriene receptor antagonists in patients with severe persistent asthma.3
There are several …